Your browser doesn't support javascript.
loading
First Reported Case of Atypical Meningioma in an Individual with Down Syndrome.
Vanderschelden, Rachel; Golshani, Kiarash; Evans, Mark G.
Afiliación
  • Vanderschelden R; Department of Pathology and Laboratory Medicine, University of Pittsburgh Medical Center, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Golshani K; Department of Neurological Surgery, University of California Irvine, Orange, California, USA.
  • Evans MG; Division of Pathology and Laboratory Medicine, Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Case Rep Neurol ; 14(1): 191-196, 2022.
Article en En | MEDLINE | ID: mdl-35611359
Individuals with Down syndrome are at decreased risk of developing most types of solid tumors, including central nervous system malignancies. Several mechanisms have been proposed to explain how additional genetic material on chromosome 21 may confer this increased protection. Only two individuals with Down syndrome and meningioma have been described in the medical literature, whose tumors were both World Health Organization (WHO) grade 1. Here, we report the first individual with Down syndrome to our knowledge who developed an atypical meningioma, WHO grade 2. We also provide a hypothesis for how this tumor could have arisen in the setting of trisomy 21.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Case Rep Neurol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Case Rep Neurol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos